|
PUT
|
$0
|
144K
|
Q2 2025
Added 15.38%
|
|
|
CALL
|
$0
|
228K
|
Q2 2025
Added 57.03%
|
|
|
PUT
|
$0
|
26.4K
|
Q2 2025
Reduced 24.14%
|
|
|
CALL
|
$0
|
368K
|
Q2 2025
Added 49.27%
|
|
|
PUT
|
$0
|
50.8K
|
Q2 2025
Reduced 16.45%
|
|
|
CALL
|
$0
|
1.6K
|
Q2 2025
Added 23.08%
|
|
|
PUT
|
$0
|
2.5K
|
Q2 2025
New holding
|
|
Amylyx Pharmaceuticals Inc
|
CALL
|
$0
|
19.1K
|
Q2 2025
Added 0.53%
|
|
Amylyx Pharmaceuticals Inc
|
PUT
|
$0
|
1.1K
|
Q2 2025
Reduced 98.67%
|
|
|
CALL
|
$0
|
126K
|
Q2 2025
Added 281.87%
|
|
|
PUT
|
$0
|
42.9K
|
Q2 2025
Added 694.44%
|
|
|
CALL
|
$0
|
22.3K
|
Q2 2025
Reduced 71.19%
|
|
|
PUT
|
$0
|
1.4K
|
Q2 2025
Reduced 68.18%
|
|
Anavex Life Sciences Corp
|
CALL
|
$0
|
251K
|
Q2 2025
Reduced 12.17%
|
|
Anavex Life Sciences Corp
|
PUT
|
$0
|
54.7K
|
Q2 2025
Added 19.96%
|
|
|
CALL
|
$0
|
500
|
Q2 2025
New holding
|
|
|
PUT
|
$0
|
9K
|
Q2 2025
New holding
|
|
|
PUT
|
$0
|
1K
|
Q1 2025
New holding
|
|
Anheuser Busch Inbev Sa/Nv
|
CALL
|
$0
|
140K
|
Q2 2025
Reduced 34.73%
|
|
Anheuser Busch Inbev Sa/Nv
|
PUT
|
$0
|
67.1K
|
Q2 2025
Reduced 2.89%
|
|
|
CALL
|
$0
|
200
|
Q2 2025
New holding
|
|
|
PUT
|
$0
|
400
|
Q2 2025
Added 300.0%
|
|
|
CALL
|
$0
|
3K
|
Q2 2025
Reduced 70.59%
|
|
|
PUT
|
$0
|
1K
|
Q2 2025
Reduced 23.08%
|
|
Annaly Capital Management In
|
CALL
|
$0
|
280K
|
Q2 2025
Added 82.27%
|
|
Annaly Capital Management In
|
PUT
|
$0
|
416K
|
Q2 2025
Added 169.82%
|
|
|
CALL
|
$0
|
18.9K
|
Q2 2025
Reduced 1.05%
|
|
|
PUT
|
$0
|
100
|
Q2 2025
Reduced 90.91%
|
|
|
CALL
|
$0
|
1.2K
|
Q2 2025
Reduced 57.14%
|
|
|
PUT
|
$0
|
10.3K
|
Q2 2025
Reduced 79.8%
|
|
|
CALL
|
$0
|
7.6K
|
Q2 2025
Added 49.02%
|
|
|
PUT
|
$0
|
54.4K
|
Q2 2025
Reduced 6.21%
|
|
|
CALL
|
$0
|
336K
|
Q2 2025
Added 117.03%
|
|
|
PUT
|
$0
|
572K
|
Q2 2025
Added 508.72%
|
|
|
CALL
|
$0
|
48.9K
|
Q2 2025
Added 115.42%
|
|
|
PUT
|
$0
|
41.8K
|
Q2 2025
Reduced 2.56%
|
|
|
CALL
|
$0
|
557K
|
Q2 2025
Reduced 12.42%
|
|
|
PUT
|
$0
|
7.9K
|
Q2 2025
Added 139.39%
|
|
|
CALL
|
$0
|
400
|
Q2 2025
New holding
|
|
|
CALL
|
$0
|
283K
|
Q2 2025
Added 146.08%
|
|
|
PUT
|
$0
|
161K
|
Q2 2025
Added 256.89%
|
|
|
CALL
|
$0
|
4K
|
Q2 2025
Reduced 97.24%
|
|
|
PUT
|
$0
|
51.2K
|
Q2 2025
Added 31.62%
|
|
Apellis Pharmaceuticals Inc
|
CALL
|
$0
|
146K
|
Q2 2025
Reduced 30.07%
|
|
Apellis Pharmaceuticals Inc
|
PUT
|
$0
|
54.5K
|
Q2 2025
Reduced 38.21%
|
|
|
CALL
|
$0
|
10K
|
Q2 2025
New holding
|
|
|
PUT
|
$0
|
200
|
Q2 2025
New holding
|
|
Midcap Financial Invstmnt CO
|
CALL
|
$0
|
24.1K
|
Q2 2025
Added 136.27%
|
|
Midcap Financial Invstmnt CO
|
PUT
|
$0
|
1K
|
Q2 2025
Added 11.11%
|
|
Apollo Coml Real Est Fin Inc
|
CALL
|
$0
|
25.5K
|
Q2 2025
Added 48.26%
|
|